Recent insider trading activity from McIntyre David, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Inhibikase Therapeutics, Inc. | $IKT | McIntyre David | Chief Financial Officer | A | Stock Option (Right to Buy) | 986319 | $0.00 | 986,319.0000 | 90,050,973 | 9999.99% | 1.10% |
| April 14, 2025 | Inhibikase Therapeutics, Inc. | $IKT | McIntyre David | Chief Financial Officer | A | Stock Option (Right to Buy) | 1775539 | $0.00 | 1,775,539.0000 | 23,712,220 | 9999.99% | 7.49% |